We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Resources
Form 483s Database
FDA Approved Drugs
White Papers
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Daniel J. Lahar
Daniel J. Lahar
Products
PRODUCTS
Biocon Sdn Bhd
Rong Guo
,
Patty Kaewussdangkul
,
Daniel J. Lahar
, and
Eileen A. Liu
Price:
$117.00
View
Respironics California, LLC
Daniel J. Lahar
Price:
$117.00
View
Encore Medical, LP
Daniel J. Lahar
Price:
$117.00
View
Linatech, LLC
Daniel J. Lahar
Price:
$117.00
View
Ningbo Besmed Medical Equipment
Daniel J. Lahar
Price:
$117.00
View
Clinicon Corp.
Daniel J. Lahar
Price:
$117.00
View
Dental Engineering Laboratories, LLC
Daniel J. Lahar
Price:
$117.00
View
Emerge Diagnostics, Inc.
Daniel J. Lahar
and
Juanj N. Wu
Price:
$117.00
View
Sotera Wireless, Inc.
Daniel J. Lahar
Price:
$117.00
View
Scantibodies Laboratory, Inc.
Daniel J. Lahar
Price:
$117.00
View
View All Products by Daniel J. Lahar
Upcoming Events
28
Sep
The Cost of Counterfeiting: Why You Need a Plan to Secure Your Medical Device Supply Chain
28
Sep
Calculating Sample Size to Satisfy FDA Expectations
11
Oct
GMP Quality Management vSummit 2023: Where Quality Meets Risk
16
Oct
MAGI@home Clinical Research Conference 2023
26
Oct
FDA in 2024: What to Expect in an Election Year
08
Nov
18th Annual FDA Inspections vSummit
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Manufacturing Cost is Key Issue Facing Gene Therapy Products, Marks Says
Artificial Womb Technology Not Yet Ready for Human Trials Adcomm Says
Top Concern for CBER is Marketing of Unapproved Biologics, Says FDA Official
FDA Deems Medline Industries’ Saline Solution Vial Recall as Class 1
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
